Literature DB >> 20453132

Regulation of neurotoxin production and sporulation by a Putative agrBD signaling system in proteolytic Clostridium botulinum.

Clare M Cooksley1, Ian J Davis, Klaus Winzer, Weng C Chan, Michael W Peck, Nigel P Minton.   

Abstract

A significant number of genome sequences of Clostridium botulinum and related species have now been determined. In silico analysis of these data revealed the presence of two distinct agr loci (agr-1 and agr-2) in all group I strains, each encoding putative proteins with similarity to AgrB and AgrD of the well-studied Staphylococcus aureus agr quorum sensing system. In S. aureus, a small diffusible autoinducing peptide is generated from AgrD in a membrane-located processing event that requires AgrB. Here the characterization of both agr loci in the group I strain C. botulinum ATCC 3502 and of their homologues in a close relative, Clostridium sporogenes NCIMB 10696, is reported. In C. sporogenes NCIMB 10696, agr-1 and agr-2 appear to form transcriptional units that consist of agrB, agrD, and flanking genes of unknown function. Several of these flanking genes are conserved in Clostridium perfringens. In agreement with their proposed role in quorum sensing, both loci were maximally expressed during late-exponential-phase growth. Modulation of agrB expression in C. sporogenes was achieved using antisense RNA, whereas in C. botulinum, insertional agrD mutants were generated using ClosTron technology. In comparison to the wild-type strains, these strains exhibited drastically reduced sporulation and, for C. botulinum, also reduced production of neurotoxin, suggesting that both phenotypes are controlled by quorum sensing. Interestingly, while agr-1 appeared to control sporulation, agr-2 appeared to regulate neurotoxin formation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20453132      PMCID: PMC2897414          DOI: 10.1128/AEM.03038-09

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  35 in total

1.  Antisense-RNA-mediated decreased synthesis of small, acid-soluble spore proteins leads to decreased resistance of clostridium perfringens spores to moist heat and UV radiation.

Authors:  Deepa Raju; Peter Setlow; Mahfuzur R Sarker
Journal:  Appl Environ Microbiol       Date:  2007-01-26       Impact factor: 4.792

2.  The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome.

Authors:  Mohammed Sebaihia; Brendan W Wren; Peter Mullany; Neil F Fairweather; Nigel Minton; Richard Stabler; Nicholas R Thomson; Adam P Roberts; Ana M Cerdeño-Tárraga; Hongmei Wang; Matthew T G Holden; Anne Wright; Carol Churcher; Michael A Quail; Stephen Baker; Nathalie Bason; Karen Brooks; Tracey Chillingworth; Ann Cronin; Paul Davis; Linda Dowd; Audrey Fraser; Theresa Feltwell; Zahra Hance; Simon Holroyd; Kay Jagels; Sharon Moule; Karen Mungall; Claire Price; Ester Rabbinowitsch; Sarah Sharp; Mark Simmonds; Kim Stevens; Louise Unwin; Sally Whithead; Bruno Dupuy; Gordon Dougan; Bart Barrell; Julian Parkhill
Journal:  Nat Genet       Date:  2006-06-25       Impact factor: 38.330

3.  The development of Clostridium difficile genetic systems.

Authors:  Nigel Minton; Glen Carter; Mike Herbert; Triona O'keeffe; Des Purdy; Mike Elmore; Anna Ostrowski; Oliver Pennington; Ian Davis
Journal:  Anaerobe       Date:  2004-04       Impact factor: 3.331

4.  Design of antisense RNA constructs for downregulation of the acetone formation pathway of Clostridium acetobutylicum.

Authors:  Seshu B Tummala; Neil E Welker; Eleftherios T Papoutsakis
Journal:  J Bacteriol       Date:  2003-03       Impact factor: 3.490

5.  Use of an EZ-Tn5-based random mutagenesis system to identify a novel toxin regulatory locus in Clostridium perfringens strain 13.

Authors:  Jorge E Vidal; Jianming Chen; Jihong Li; Bruce A McClane
Journal:  PLoS One       Date:  2009-07-14       Impact factor: 3.240

6.  Antisense RNA downregulation of coenzyme A transferase combined with alcohol-aldehyde dehydrogenase overexpression leads to predominantly alcohologenic Clostridium acetobutylicum fermentations.

Authors:  Seshu B Tummala; Stefan G Junne; Eleftherios T Papoutsakis
Journal:  J Bacteriol       Date:  2003-06       Impact factor: 3.490

Review 7.  Biology and genomic analysis of Clostridium botulinum.

Authors:  Michael W Peck
Journal:  Adv Microb Physiol       Date:  2009       Impact factor: 3.517

8.  Identification of the agr locus of Listeria monocytogenes: role in bacterial virulence.

Authors:  Nicolas Autret; Catherine Raynaud; Iharilalao Dubail; Patrick Berche; Alain Charbit
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  The ClosTron: a universal gene knock-out system for the genus Clostridium.

Authors:  John T Heap; Oliver J Pennington; Stephen T Cartman; Glen P Carter; Nigel P Minton
Journal:  J Microbiol Methods       Date:  2007-06-18       Impact factor: 2.363

10.  Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum.

Authors:  Andrew T Carter; Catherine J Paul; David R Mason; Susan M Twine; Mark J Alston; Susan M Logan; John W Austin; Michael W Peck
Journal:  BMC Genomics       Date:  2009-03-19       Impact factor: 3.969

View more
  52 in total

1.  Involvement of two-component system CBO0366/CBO0365 in the cold shock response and growth of group I (proteolytic) Clostridium botulinum ATCC 3502 at low temperatures.

Authors:  Miia Lindström; Elias Dahlsten; Henna Söderholm; Katja Selby; Panu Somervuo; John T Heap; Nigel P Minton; Hannu Korkeala
Journal:  Appl Environ Microbiol       Date:  2012-06-01       Impact factor: 4.792

Review 2.  Peptide signaling in the staphylococci.

Authors:  Matthew Thoendel; Jeffrey S Kavanaugh; Caralyn E Flack; Alexander R Horswill
Journal:  Chem Rev       Date:  2010-12-21       Impact factor: 60.622

Review 3.  Potential Emergence of Multi-quorum Sensing Inhibitor Resistant (MQSIR) Bacteria.

Authors:  Shikha Koul; Jyotsana Prakash; Anjali Mishra; Vipin Chandra Kalia
Journal:  Indian J Microbiol       Date:  2015-11-04       Impact factor: 2.461

4.  A novel regulator controls Clostridium difficile sporulation, motility and toxin production.

Authors:  Adrianne N Edwards; Rita Tamayo; Shonna M McBride
Journal:  Mol Microbiol       Date:  2016-03-22       Impact factor: 3.501

5.  The Agr-like quorum-sensing system regulates sporulation and production of enterotoxin and beta2 toxin by Clostridium perfringens type A non-food-borne human gastrointestinal disease strain F5603.

Authors:  Jihong Li; Jianming Chen; Jorge E Vidal; Bruce A McClane
Journal:  Infect Immun       Date:  2011-04-04       Impact factor: 3.441

Review 6.  Sporulation and Germination in Clostridial Pathogens.

Authors:  Aimee Shen; Adrianne N Edwards; Mahfuzur R Sarker; Daniel Paredes-Sabja
Journal:  Microbiol Spectr       Date:  2019-11

7.  Positive regulation of botulinum neurotoxin gene expression by CodY in Clostridium botulinum ATCC 3502.

Authors:  Zhen Zhang; Elias Dahlsten; Hannu Korkeala; Miia Lindström
Journal:  Appl Environ Microbiol       Date:  2014-10-03       Impact factor: 4.792

8.  The CpAL quorum sensing system regulates production of hemolysins CPA and PFO to build Clostridium perfringens biofilms.

Authors:  Jorge E Vidal; Joshua R Shak; Adrian Canizalez-Roman
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

9.  The key sigma factor of transition phase, SigH, controls sporulation, metabolism, and virulence factor expression in Clostridium difficile.

Authors:  Laure Saujet; Marc Monot; Bruno Dupuy; Olga Soutourina; Isabelle Martin-Verstraete
Journal:  J Bacteriol       Date:  2011-05-13       Impact factor: 3.490

10.  Epigallocatechin gallate and Lactobacillus plantarum culture supernatants exert bactericidal activity and reduce biofilm formation in Clostridium perfringens.

Authors:  Alberto Aguayo-Acosta; Eduardo Franco-Frías; Norma Heredia; Jose A Merino-Mascorro; Jorge E Dávila-Aviña; Jorge E Vidal; Santos García
Journal:  Folia Microbiol (Praha)       Date:  2021-06-25       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.